I 
110TH CONGRESS 
1ST SESSION 
H. R. 972 
To provide compensation to individuals who, during the Vietnam conflict, 
were employees of the Federal Government or contractor employees of 
the Department of Defense and suffered disability or death from exposure 
to Agent Orange. 
IN THE HOUSE OF REPRESENTATIVES 
FEBRUARY 8, 2007 
Mr. WEXLER (for himself, Mr. FILNER, Mr. KUCINICH, Mr. MORAN of Vir-
ginia, Mr. MCNERNEY, Ms. JACKSON-LEE of Texas, and Mr. GONZALEZ) 
introduced the following bill; which was referred to the Committee on the 
Judiciary 
A BILL 
To provide compensation to individuals who, during the Viet-
nam conflict, were employees of the Federal Government 
or contractor employees of the Department of Defense 
and suffered disability or death from exposure to Agent 
Orange. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Civilian Agent Orange 
Act of 2007’’. 
VerDate Aug 31 2005 
21:20 Feb 14, 2007
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H972.IH
H972
pwalker on PROD1PC71 with BILLS
SEC. 2. DEFINITIONS. 
In this Act: 
(1) EXPOSED EMPLOYEE.—The term ‘‘exposed 
employee’’ means an individual who— 
(A) during the Vietnam conflict— 
(i) was a civilian employee of the Fed-
eral Government, or an employee of a con-
tractor (or subcontractor at any tier) of 
the Department of Defense; and 
(ii) while so employed, was— 
(I) physically present in the Re-
public of Vietnam during the period 
beginning January 9, 1962, and end-
ing on May 7, 1975; or 
(II) in or near the Korean demili-
tarized zone during the period begin-
ning September 1, 1967, and ending 
on August 31, 1971; 
(B) contracted an Agent Orange illness; 
and 
(C) suffered injury or death by reason of 
that illness. 
(2) 
AGENT
ORANGE
ILLNESS.—The 
term 
‘‘Agent Orange illness’’ means an illness listed by 
the National Institute of Medicine as having at least 
a limited or suggestive association with 2,4- 
VerDate Aug 31 2005 
21:20 Feb 14, 2007
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H972.IH
H972
pwalker on PROD1PC71 with BILLS
dichlorophenoxyacetic 
acid 
(2,4-D), 
1,4,5- 
trichlorophenoxyacetic acid (2,4,5-T), 4-amino-3,5,6- 
trichloropicolinic acid (picloram), and cacodylic acid 
(dimenthylarsenic 
acid, 
DMA), 
and 
2,3,7,8- 
tetrachlorodibenzo-p-dioxin (TCDD, or dioxin). 
SEC. 3. COMPENSATION PROGRAM. 
(a) IN GENERAL.—There is hereby established a pro-
gram to be known as the ‘‘Agent Orange Illness Com-
pensation Program’’ (in this Act referred to as the ‘‘com-
pensation program’’), to be carried out by the Attorney 
General. 
(b) PURPOSE.—The purpose of the compensation 
program is to provide for timely, uniform, and adequate 
compensation of exposed employees and, where applicable, 
survivors of such employees, suffering from Agent Orange 
illnesses incurred by such employees. 
SEC. 4. COMPENSATION FUND. 
(a) ESTABLISHMENT.—There is hereby established 
on the books of the Treasury a fund to be known as the 
‘‘Agent Orange Illness Compensation Fund’’ (in this Act 
referred to as the ‘‘compensation fund’’). 
(b) AMOUNTS.—The compensation fund shall consist 
of the following amounts: 
(1) Amounts appropriated to the compensation 
fund pursuant to an authorization of appropriations. 
VerDate Aug 31 2005 
21:20 Feb 14, 2007
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H972.IH
H972
pwalker on PROD1PC71 with BILLS
(2) Amounts transferred to the compensation 
fund. 
(c) FINANCING.—Upon the exhaustion of amounts in 
the compensation fund, the Secretary of the Treasury 
shall transfer directly to the compensation fund from the 
General Fund of the Treasury, without further appropria-
tion, such amounts as are further necessary to carry out 
the compensation program. 
(d) USE.—Subject to subsection (e) of this section, 
amounts in the compensation fund shall be used to carry 
out the compensation program. 
(e) ADMINISTRATIVE
COSTS
NOT
PAID
FROM 
FUND.—No cost incurred in carrying out the compensa-
tion program, or in administering the compensation fund, 
shall be paid from the compensation fund. 
(f) MONETARY ALLOWANCE NOT TO BE CONSID-
ERED AS INCOME OR RESOURCES FOR CERTAIN PUR-
POSES.—Notwithstanding any other provision of law, a 
monetary allowance paid an individual under this Act shall 
not be considered as income or resources in determining 
eligibility for, or the amount of benefits under any Federal 
or federally assisted program. 
(g) INVESTMENT.—Amounts in the compensation 
fund shall be invested in accordance with section 9702 of 
title 31, and any interest on, and proceeds from, any such 
VerDate Aug 31 2005 
21:20 Feb 14, 2007
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H972.IH
H972
pwalker on PROD1PC71 with BILLS
investment shall be credited to and become a part of the 
compensation fund. 
(h) AUTHORIZATION OF APPROPRIATIONS.—There is 
hereby authorized to be appropriated $100,000,000 to the 
compensation fund. 
SEC. 5. COMPENSATION TO BE PROVIDED. 
(a) IN GENERAL.—An exposed employee, or the eligi-
ble survivor of that employee if the employee is deceased, 
shall receive compensation for the injury, illness, or death 
of that employee from that employee’s Agent Orange ill-
ness in an amount determined under subsection (b). 
(b) AMOUNT.—For each exposed employee, the Attor-
ney General shall provide compensation in the amount of 
$100,000. 
(c) PAYMENTS IN THE CASE OF DECEASED PER-
SONS.— 
(1) SURVIVORS ELIGIBLE.—In the case of an 
exposed employee who is deceased at the time of 
payment of compensation under this section, wheth-
er or not the death is the result of the employee’s 
Agent Orange illness, such payment may be made 
only as follows: 
(A) If the employee is survived by a spouse 
who is living at the time of payment, such pay-
ment shall be made to such surviving spouse. 
VerDate Aug 31 2005 
21:20 Feb 14, 2007
Jkt 059200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H972.IH
H972
pwalker on PROD1PC71 with BILLS